Search for Nurse Practitioner Events

The most comprehensive directory of national, statewide and local nurse practitioner events

Tzield: a CD3- directed monoclonal antibody indicated to delay the onset of stage 3 type 1 diabetes in adults and pediatic patiients (>8 years) with stage 2 TID

Maggiano's Little Italy
516 North Clark Street
Chicago, IL 60654

Thursday, July 11, 2024 at 5:30pm CT - 8:30pm CT
This event has ended.

Posted by The Illinois Chicago Chapter of NAPNAP

516 North Clark Street, Chicago, IL 60654



Deepen understanding of disease, autoimmunity, and the pathogenesis of T1D, enhance understanding of the stages of T1D and need to screen patients for T1D-related autoantibodies, illustrate the mechanism of action of Tzield, important safety information, patient selection criteria, dosing, and clinical data

Additional Information
Additional Information: The Illinois Chapter of NAPNAP is excited to partner with Sanofi to offer this FREE non-CE dinner. This event is fully sponsored by Sanofi and we welcome all nurse practitioners that are interested in attending. 

Registration and socialization from 6-6:30pm, dinner and presentation promptly at 6:30pm. 

Dinner included in registration!

Parking Options: 
Spot Hero 
Street Meter Parking 


Mary McCauley MD

Attending Physician